PubMed · 5607596
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
1967-06-30. [Daunomycin].. https://pubmed.ncbi.nlm.nih.gov/5607596/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
A series of [(o-acylaryl)oxy]propanolamines have been prepared and evaluated for multidrug resistance-reverting activity in a human tumor cell model. Structure-activity relationship studies indicate that the phenylpropiophenone moiety as well as the substitution pattern at the nitrogen atom is crucial for activity of the compounds. Incorporation of the ether oxygen into a benzofuran substructure, which renders the compound an arylethanolamine, decreased biologic activity. Highest activity could be observed with the arylpiparazines 4f-h, which not only completely restored daunomycin sensitivity but also showed moderate activity in restoring etoposide toxicity.
We have investigated the effect of doxorubicin (Adriamycin) on the yeast Saccharomyces cerevisiae. Drug treatment was found to be cytotoxic to wild-type strains, in a concentration-dependent manner, whereas a petite mutant lacking the cytochrome oxidase (EC 1.9.3.1) subunit IV gene was resistant to doxorubicin. Transformation of the doxorubicin-resistant mutant with a yeast in vivo expression vector harboring the cytochrome oxidase subunit IV gene restored both respiration and sensitivity to doxorubicin. Another petite strain, with a mutation in the mitochondrial adenine nucleotide translocator (pet9), did not display doxorubicin resistance. However, in contrast to the subunit IV mutant, it possesses a functional respiratory chain. We also compared the cytotoxic effect of doxorubicin with those of daunorubicin and mitoxantrone in yeast. We found comparable levels of cytotoxicity for doxorubicin and daunorubicin, which were significantly greater than that for mitoxantrone. Finally, we constructed a yeast strain that overexpresses manganese superoxide dismutase (EC 1.15.1.1), an antioxidant enzyme present in mitochondria. Overexpression of manganese superoxide dismutase protected significantly against doxorubicin and daunorubicin cytotoxicity but only slightly against mitoxantrone cytotoxicity. Collectively, our results provide direct in vivo evidence that superoxide radicals participate in doxorubicin- and daunorubicin-induced cytotoxicity in yeast. Furthermore, these results indicate that mitochondrial respiration is a crucial factor in anthracycline, and perhaps mitoxantrone, cytotoxicity in yeast.
The first reports on promyelocytic leukaemia came from Norway and France in 1957. Little by little, acute promyelocytic leukaemia acquired its rightful place in nosology as a hyperacute, invariable and rapidly fatal disease. In 1973, a high frequency of complete remissions induced by strong doses of daunorubicin and an acceptable frequency of true recovery, was demonstrated. After these preliminary events, the history of promyelocytic leukaemia was that of an important discovery: the first remissions of human acute leukaemia were obtained by cell differentiation, as all-trans retinoic acid induces complete remission of acute promyelocytic leukaemia in nearly all cases. The consequences of the discovery are discussed. For the long or middle term, we can hope for improved understanding of the action of retinoic acid, and possibly the preparation of new compounds with longer efficiency.